SCHEMBL12292499

SCHEMBL12292499

CS(=O)(=O)c1ccc(-c2ccc(/C=C3/SC(=O)N(Cc4ccco4)C3=O)o2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 5/20 0.49
▸ KMT2A Q03164 5/20 0.49
▸ RECQL P46063 2/20 0.49
▸ BLM P54132 2/20 0.49
▸ TDP1 Q9NUW8 2/20 0.49
▸ ENPP2 Q13822 1/20 0.49
▸ ITGB2 P05107 3/20 0.48
▸ ITGAM P11215 3/20 0.48
▸ PPARG P37231 2/20 0.46
▸ MAPT P10636 3/20 0.43
▸ CYP1A2 P05177 1/20 0.43
▸ CYP3A4 P08684 1/20 0.43
▸ CYP2D6 P10635 1/20 0.43
▸ CYP2C19 P33261 1/20 0.43
▸ PTPN22 Q9Y2R2 3/20 0.43
▸ POLB P06746 3/20 0.43
▸ ALDH1A1 P00352 2/20 0.43
▸ KDM4E B2RXH2 1/20 0.43
▸ PKM P14618 1/20 0.43
▸ HPGD P15428 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12292501 0.90 MEN1 (0.47) MEN1KMT2ARECQLBLMTDP1
SCHEMBL12292504 0.88 MEN1 (0.52) MEN1KMT2ARECQLBLMTDP1
SCHEMBL683937 0.87 ITGB2 (0.58) MEN1KMT2ARECQLBLMTDP1
SCHEMBL12292503 0.87 ENPP2 (0.48) MEN1KMT2ARECQLBLMTDP1
SCHEMBL12291201 0.86 MEN1 (0.65) MEN1KMT2ARECQLBLMTDP1
SCHEMBL12292506 0.86 ENPP2 (0.54) MEN1KMT2ARECQLBLMTDP1
SCHEMBL12291206 0.86 ENPP2 (0.54) MEN1KMT2ARECQLBLMTDP1
SCHEMBL12291214 0.86 ITGB2 (0.59) MEN1KMT2ARECQLBLMTDP1
SCHEMBL12292508 0.85 ENPP2 (0.57) MEN1KMT2ARECQLBLMTDP1
SCHEMBL12292498 0.84 MEN1 (0.47) MEN1KMT2ARECQLBLMTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011133719-A2 ANTI-VIRAL COMPOUNDS Kineta, Inc. (US) 2011-10-27 — — WO disclosed
Send feedback